SFL’s Director of Regulatory Affairs Suzanne Einmahl and Director of Medical Affairs Daniela Kenzelmann Broz will attend the Swiss Biotech Insight event on “Clinical trial strategy: Fine-tuning the risk-reward profile” (19 September 2019, Lausanne). The event hosts speakers discussing strategies in developing innovative clinical products from idea to proof-of-concept, harnessing new technologies in drug development, changing regulatory frameworks and future opportunities in drug development.

SFL provides both strategic as well as operational support for projects covering all life-cycle stages from early development to regulatory maintenance and commercialization of approved healthcare products, utilizing its unique combination of expertise and a multi-disciplinary approaContact us to arrange a meeting to discuss how SFL can support your projects.